Tyra Biosciences CEO Harris Todd Receives 864 Shares Under ESPP

What Happened

• Harris Todd, President & CEO and a director of Tyra Biosciences (TYRA), acquired 864 shares on September 15, 2026. The shares were purchased at $9.13 each for a total cost of $7,887. The filing reports the transaction as an acquisition/award (code A), and the shares were obtained under the issuer's 2021 Employee Stock Purchase Plan.

Key Details

• Transaction date: 2026-09-15; Price: $9.13 per share; Shares acquired: 864; Total value: $7,887.
• Filing date / accession: Form 4 filed 2026-09-17 (Accession 0001193125-26-394738) — filed within the routine two-business-day window.
• Footnotes: F1 — shares acquired under the 2021 Employee Stock Purchase Plan (ESPP). F2 — filing notes that reported holdings include restricted stock units (RSUs).
• Shares owned after the transaction: not specified in the summary data provided in your request.

Context

• This was an ESPP acquisition (employee purchase), a routine way executives and employees accumulate company stock, often through payroll deductions and at a discount. The transaction did not report any immediate sale of the acquired shares. The dollar amount (~$7.9k) is modest compared with many insider trades.